Cardiometabolic Disorders News

Women exposed to higher concentrations of a class of endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances are at increased risk for incident hypertension, researchers reported.

ATLANTA — Prediabetes, with HbA1c below the diagnostic level for type 2 diabetes, may be an independent risk factor for myocardial infarction, percutaneous coronary intervention and coronary artery bypass grafting, according to study data.

ATLANTA — Adolescent boys with overweight, obesity, hyperinsulinemia or insulin resistance have a lower testicular volume compared with those with normal weight, according to a presenter at ENDO 2022.

The cholesterol benefits of bempedoic acid plus background therapy were consistent across subgroups of patients with hypertension, metabolic syndrome and renal impairment, researchers reported.

Experts from across the field of endocrinology will gather in Atlanta beginning Saturday for the first in-person Endocrine Society annual meeting in 3 years.

NEW ORLEANS — In part 2 of this video exclusive, James R. Gavin III, MD, PhD, talks with Anne L. Peters, MD, about a nonprofit model for expanding access to diabetes care.

Healthy lifestyle habits before and during menopause may delay or lessen severe metabolic conditions in women caused by potential increases in adiposity, according to findings published in Aging Cell.

NEW ORLEANS — In the third part of this video exclusive, James R. Gavin III, MD, PhD, talks with Jamy D. Ard, MD, about new drugs for substantial weight loss and treatment of obesity-related comorbidities, including type 2 diabetes and liver disease.

NEW ORLEANS — In this video exclusive, James R. Gavin III, MD, PhD, talks with Jamy D. Ard, MD, about the misleading concept of metabolically healthy obesity, its effect of delaying early treatment and the benefit of small weight losses.

NEW ORLEANS — There is no single answer when it comes to determining the primary target for treating type 2 diabetes, two speakers said during a debate at the American Diabetes Association Scientific Sessions.